This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.
This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.

Composit M Study Infographic 

Prescribing Information

Find out how early initiation of JANUVIA (Sitagliptin) during metformin up-titration can help your patients.1

More than 11 years of experience:2 the evidence continues to build for JANUVIA (Sitagliptin)


Significantly greater reductions in HbA1C with early initiation of JANUVIA during Metformin up-titration vs metformin up-titration alone


Significantly greater proportion of patients reached HbA1C <7% with early initiation of Januvia during metforming up-titration vs metforming up-titration alone

download

PDF 680 KB

 

Download a digital infographic of the CompoSIT-M study: A randomized clinical trial of the efficacy and safety of the addition of sitagliptin during metformin up-titration compared with metformin up-titration alone in adults with type 2 diabetes mellitus. 1

This resource has been initiated and produced by MSD.


References:

  1. Frias JP et al. Double-blind, randomized clinical trial assessing the efficacy and safety of early initiation of sitagliptin during metformin up-titration in treatment of patients with type 2 diabetes: the CompoSIT-M Study. https://doi:10.1111/dom.13626
  2. JANUVIA Summary of Product Characteristics

For more information about JANUVIA® (sitagliptin):


Supporting documentation

JANUVIA (Sitagliptin) 100 mg
Prescribing Information | Summary of Product Characteristics | Patient Information Leaflet

JANUVIA (Sitagliptin) 50 mg
Prescribing Information | Summary of Product Characteristics | Patient Information Leaflet

JANUVIA (Sitagliptin) 25 mg
Prescribing Information | Summary of Product Characteristics | Patient Information Leaflet

GB-DIA-00721 | Date of Preparation:February 2020